Summary
Despite a considerable decrease in their incidence worldwide, burn injuries remain one of the commonest forms of trauma and account for a weighty proportion of trauma cases in health-care emergencies around the globe. Although the latest data reveal a substantial decline in burn-related mortality and hospital admissions in the US over the past three decades, severe thermal injuries continue to trigger devastating morbidity and significant mortality while their management remains a dynamic challenge for the entire medical and paramedical community. Concrete evidence continues to be established regarding burn-associated pathophysiologic responses, and their destructive sequelae and deleterious effects in survivors at cellular, systemic as well as socio-economic level. Better understanding of these responses have contributed to advances in therapeutic strategies, improved long-term outcomes and catalyzed the reintegration of victims back into society. This paper describes the current understanding of the pathophysiology of a burn injury and characterizes both local and systemic pathophysiologic responses in terms of metabolic, hemodynamics, cardiac, renal, hepatic, gastro-intestinal, immunologic, endocrine as well as male reproductive systems in an attempt to understand the corresponding treatment modalities for this unique patient population.
Keywords: burn injury, major burns, pathophysiology, modulators
Abstract
Malgré une diminution importante de leur incidence mondiale, les brûlures demeurent un des traumatismes les plus fréquents et représentent une proportion importante des traumatismes nécessitant un recours aux services d’urgences. Bien que les dernières données étatsuniennes montrent une diminution de la mortalité et des hospitalisations liées aux brûlures sur les 30 dernières années, les brûlures étendues restent responsables d’une mortalité significative et d’une morbidité considérable dont la prise en charge reste un défi pour la communauté soignante. Des données factuelles continuent à s’accumuler concernant la physiopathologie des brûlures et ses conséquences, aux niveaux cellulaire comme systémique et socio-économique. La meilleure compréhension de cette physiopathologie a permis des progrès dans la stratégie thérapeutique, ayant pour objectif d’améliorer l’évolution à distance et la réintégration sociétale. Cet article décrit les connaissances actuelles de la physiopathologie des brûlures et les caractéristiques locales comme systémiques des réponses aux niveaux métabolique, hémodynamique, cardiaque, rénal, hépatique, gastro-intestinal, immunologique, endocrine (comprenant le système reproducteur masculin) afin de comprendre les modalités de traitement de ce groupe de patients.
Introduction
The number of burn injury victims in the United States is estimated to be 1.2 million per year, with an annual incidence of 2 million fire accidents reported.1 Among these injuries, 75% are considered mild, treated on an outpatient basis, 2,3 while on average 50,000 burn patients require admission to a hospital or major burn center.4
Despite a considerable decrease in the incidence of burns in the developed world, they remain one of the commonest forms of injury, accounting for a significant proportion of trauma cases in hospital emergencies worldwide, and they continue to cause devastating morbidity and mortality.5,6 The distressing consequences of burns have been recognized by the medical community, and significant amounts of resources and research have been dedicated to successfully improving these dismal statistics. Recent reports revealed a 50% decline in burn-related deaths and hospital admissions in the USA over the last 20 years. This is attributable to the effective prevention strategies that have been introduced to the practice, limiting burn-associated morbidities as well as reducing the number and severity of burns.7,8,9,10
Local changes
Burn injury triggers coagulative necrosis of the different layers of the skin as well as the underlying tissues. The gravity of the damage is determined by the energy carried by the causative agent, the spell of exposure, in addition to the temperature to which the skin is exposed.
Thermal injuries are categorized based on their etiology and depth of injury. Causative agents include fire, scald and contact with hot/cold objects. They contribute to coagulative necrosis by inducing tissue damage through transfer of energy. Other causative agents include exposure to chemicals and conduction of electricity. In addition to transfer of heat, chemical and electrical burns also induce direct damage to cellular membranes. Thanks to its major function as a reliable barrier reducing heat transfer to underlying tissues, the skin usually restricts the propagation of damage into the deep layers; however, injury of underlying tissues still occurs secondary to local tissue responses. In principle, three zones can be identified at the site of cutaneous injuries:
Zone of coagulation: this zone confines the area of necrosis. It is characterized by irreversibly damaged tissues at the time of injury.
Zone of stasis: lying adjacent to the zone of coagulation, this area is subject to a moderate degree of damage associated with vascular leakage, elevated concentrations of vasoconstrictors as well as local inflammatory reactions resulting in compromised tissue perfusion.11 Depending on the wound environment, this zone can either survive or proceed into necrosis.
Zone of hyperemia: secondary to inflammation-induced vasodilation, this zone is characterized by increased blood supply with healthy tissues under no major jeopardy for demise.
Systemic changes
Burns exceeding 30% of total body surface area (TBSA) result in considerable hypovolemia coupled with formation and release of inflammatory mediators with subsequent systemic effect, namely a distinctive cardiovascular dysfunction known as burn shock.12,13,14 Burn shock is a complex process of circulatory and microcirculatory impairment as well as edema generation in both traumatized and non-traumatized tissues. Even with timely and adequate fluid support, this pathophysiologic state remains incompletely reversible. In fact, burn shock involves an anomalous condition of inadequate tissue perfusion with resultant insufficient oxygen and nutrient delivery as well as failure to remove waste products from tissues. Despite proper fluid resuscitation and adequate preload, pulmonary and systemic vascular resistances are increased and myocardial depression follows.14,15,16,17,18 This, in turn, will stimulate further exacerbation of the inflammatory response and contribute to the risk of organ failure.13,14,19
A typical immediate response after a thermal insult is plasma extravasation followed by a sequence of hemodynamic events. The most common hemodynamic changes include diminished plasma volume, cardiac output and urine output as well as increased systemic vascular resistance (SVR) with resultant reduced peripheral blood flow.12,14,20,21,22 Unlike in hemorrhage, burn insults are associated with an increase in hemoglobin and hematocrit.
Edema formation is another characteristic reaction of burn injuries. As the ratio of fluid filtered out of microvessels to fluid entering them becomes more than 1, edema is developed. The process of edema formation is biphasic. Initiated in the first hour following burn trauma, the primary phase witnesses an abrupt increase in the water content of traumatized tissues.21,22,23 The second phase involves a more gradual increase in fluid flux of both burned and intact skin and soft tissues 12-24 hours post-burn.13-13
Of significant importance is the rapidity of tissue water content increase. Double the original volume is usually reached during the first hour, with 90% of this change observed in the initial few minutes.21,24,25,26 Whether fluid resuscitation is provided or not determines the amount of edema development. Following burn-induced plasma extravasation, additional extravasation occurs following resuscitation since fluid support increases blood flow and capillary pressure. On the other hand, the edema remains self-limited when no fluid is administered. In addition to the trauma type and extent, type and amount of administered fluid also play a key role in determining the volume of edema.21,27,28
Thermal insults additionally have a major impact on cellular membranes. Cellular transmembrane potentials in skeletal muscles distant to the site of injury are subject to a systemic decrease when the burn size exceeds 30% of TBSA.16 Furthermore, it has been proven that both directly and indirectly traumatized cells experience tissue edema following cell membrane alterations and increased sodium and potassium fluxes. Cellular membranes in injured and intact skeletal muscles demonstrate partial depolarization of membrane potential from -90mV to -70mV and -80mV. As soon as the decrease in membrane potentials is initiated, water and sodium contents within cells increase.29,30,31 Those alterations are also seen in cases of hemorrhagic shock. Reports of similar changes encountered in cardiac, hepatic and endothelial cells have been published.29,30,31,32,33,34 The driving forces responsible for membrane depolarization have been a subject of debate. Some authors attribute membrane depolarization to a decrease in ATP and reduced ATPase activity. Others postulated increased sodium conductance in membranes and enhanced sodium-hydrogen antiport activity as the etiologies behind membrane depolarization. 23,30 Several studies have been conducted aiming at identifying the factors responsible for the cellular edema seen in burn shock. It has been postulated that membrane depolarization could be attributed to the presence of unidentified complex circulating shock factor(s).35,36,37 This hypothesis has been supported by the failure of resuscitative measurements to fully restore membrane potential and intracellular sodium concentration to normal levels. By concluding that burn-associated tissue edema is not solely caused by hypovolemia, burn shock, thereby, should not be considered just as another form of hemorrhage. 38
Immense energy needs is a typical finding in victims of burns. Measured by resting energy expenditure, the metabolic rate reaches astronomical levels depending on the size of burn. The resting metabolic rates in mild burns (less than 10% TBSA) are quantified to be near normal levels. These rates rapidly increase to 2-fold of the basal rate in burns exceeding 40% of TBSA during acute admission. Following this curvilinearfashioned increase, resting metabolic rate in severely burned patients starts to decrease progressively to reach 150% of the basal rate at the time of burn wound healing. Resting metabolic rates at 6, 9 and 12 months post trauma are calculated to be 140%, 120% and 110% of the basal rate respectively.39
The hypermetabolic response has deleterious effects and devastating sequelae at cellular and systemic level, as well as socio-economic consequences for the victim. The structure and function of essential organs (heart, liver, skeletal muscle, skin), the immune system and the cellular membrane transport system are compromised while wound healing is impaired, infection risk is increased, rehabilitation is hampered and reintegration of survivors back into society is delayed.40,41,42 The hypermetabolic response is the result of a series of events triggered by a significant and persistent rise in secretions of cateholamine, cortisol, glucagon and dopamine.39,43,44,45,46,47,48,49,50 Several factors have been identified to regulate metabolic response and alter glucose metabolism for up to 3 years after the initial insult. The list of these mediators includes interleukins (IL) 1 and 6, platelet-activating factor (PAF), tissue necrosis factor (TNF), reactive oxygen species (ROS) and complement cascades.51,52,53 These metabolic regulations have been found to occur in 2 phases: early and late. The ‘Ebb’ phase starts immediately following thermal injury. It lasts for three days with a characteristic hypometabolic state associated with hypodynamic circulation, decreased oxygen consumption and hyperglycemia. These variables later start to progressively increase until reaching the ‘Flow’ phase. This hypermetabolic phase lasts for up to 1 year.39,54,55,56
In response to burn injury, alterations in metabolic pathways and pro-inflammatory cytokines promote the shift of muscle protein metabolism into a faster rate of degradation than synthesis.56,57,58,59 Significant net protein loss becomes evident in the form of negative whole-body and cross-leg nitrogen balance.58,60,61 Accelerated protein degradation contributes to a remarkable decrease in lean body mass (LBM) and muscle wasting associated with a decrease in strength and delay in rehabilitation. 61,62 Several dysfunctions and impairments follow depending on the magnitude of LBM loss. While alterations in the immune system, increase in rate of infection and delay in wound healing are correlated with a 20% loss of LBM, inhibited cough reflexes, prolonged mechanical ventilatory requirements as well as increased risk for pneumonia and pressure ulcers are seen in patients who lose 30% of their lean body mass. When loss reaches 40%, the mortality rate varies between 50-100%.63
Energy substrate metabolism is also modified as a result of the metabolic changes seen in severe burns. Glucose is consumed through anaerobic pathways with resultant high lactate production.64,65,66,67 Patients with severe burns experience increased glucose production, particularly from alanine.68 Amino acids become the main fuel for glucose generation through gluconeogenesis, leaving very few of them involved in their original function as building blocks of body protein. Nitrogen excretion, primarily in urea, increases and the body becomes short of protein storage. An important finding observed in patients with severe burns is the development of insulin-resistance. Despite a 2-fold increase in insulin levels, plasma glucose levels remain significantly elevated, reaching up to 180mg/dl.69,70,71 Persistent hyperglycemia is explained by an increase in gluconeogenic substrates, attenuation of the suppressive effect of insulin on hepatic glucose release, enhanced hepatic glycogenolysis, and impaired glucose disposal. Glycerol, alanine and lactate are gluconeogenic substrates that are increased in burns secondary to enhanced adipose tissue lipolysis and skeletal muscle proteolysis. Glycogenolysis enhancement, in burns, is secondary to the direct effect of sympathetic stimulation as well as catecholamine.72,73,74,75,76,77,78
Cardiac function is subject to several modifications starting at the time of injury. Before any plasma volume reduction is detected, receptors on thermally affected skin induce a neurogenic response initiating a rapid cardiac output depression. This is associated with an initial reduction followed by a remarkable increase in cardiac index starting on the third day.56 Other common findings include long-term increase in cardiac work, myocardial oxygen consumption and heart rate, which remain elevated during the recovery period.57,79,80 As cardiac stress becomes massive, myocardial depression ensues. Fluid resuscitation usually fails to resume normal cardiac output. This persistent depression is justified by hypovolemia, high SVR, low venous return, and the effects of myocardial depressant substance.81
The renal system is also affected following alterations in the cardiovascular system. Renal blood flow and glomerular filtration rate (GFR) are reduced secondary to hypovolemia, diminished cardiac output, and the effects of angiotensin, vasopressin and aldosterone. These alterations are usually translated in the form of oliguria as an early sign of renal compromise. Failure to promptly and adequately manage these cases may lead to acute tubular necrosis (ATN), renal failure and mortality.82,83
As thermal trauma seldom spares the hepatic function, a severe burn affects expression of acute phase proteins. Both serum complement C3 and α2- macroglobulin levels experience an initial fall followed by a gradual rise over time.56 Substantial depletion of constitutive hepatic proteins is also prominent secondary to decreased production or accelerated consumption or loss.56 In addition, alterations in serum levels of triglycerides and free fatty acids are highlighted, both of which are significantly increased secondary to a decrease in fat transporter proteins rendering the liver susceptible for fatty infiltration and hepatomegaly with resultant increased risk of sepsis and burn mortality.56
The effects of burns on the gastrointestinal system should not be underestimated, as demonstrated by mucosal atrophy, reduced absorptive capacity, and increased surface permeability. 84 In proportion to burn size, apoptotic epithelial cell death occurs, stimulating bowel mucosa degeneration.85 Mucosal atrophy subsequently leads to several defects in the absorptive function of the digestive system, notably the uptake of glucose, amino acids as well as fatty acids. Brush border lipase activity is also disturbed.86 Increase in bowel permeability to macromolecules is also noted following alterations in intestinal blood supply.87
Endocrine response is among the systemic reactions exhibited by severely injured burn patients. Characterized by significant alterations in the hypothalamic-anterior-pituitaryperipheral-hormone axes, this response follows a biphasic pattern. Target-organ resistance is considered to be responsible for the low levels of effector hormones seen in the acute phase. In the long-term phase, on the other hand, decreased levels of target organ hormones are due to suppression at the level of the hypothalamus.88 Among the hormones actively involved at the onset of injury are catecholamine, glucagon and cortisol, collectively labelled as stress hormones. These hormones display an exponential increase in their levels, sometimes reaching 10-fold their normal values.89,90,91 The significance of such an upsurge resides in its influence on the cardiovascular system and the resultant fluid shifts that follow these changes. The stress hormones are thereby considered as the initiators of the hyper metabolic -catabolic and proteolytic - response.91 Subsequent to the initial stress-related hormonal response, alterations occur at several points in the hypothalamic-pituitary-organ axes. Growth Hormone – Insulin-Like Growth Factor-1 (GH-IGF-1) axis is considered as one of the essential axes to be affected in severe burns. Of significant importance is the fact that IGF-1 and Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) were found to be much more affected when compared to GH.92,93,94,95 During the acute post-burn phase, decrease in Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4), Testosterone, Osteocalcin and Parathyroid Hormone (PTH) are also not uncommon.
Regarding the effects of burn on the male reproductive system, thermal insults commonly affect the histology of seminiferous epithelium with germ cell atrophy being the most typical change encountered followed by sloughing.96 The etiologies of germ cell apoptosis and alterations in spermatogenesis are multifactorial: scrotal temperature, hormonal reduction, systemic trauma and oxidative stress following under-perfusion.97,98,99,100 Depletion of testosterone concentrations in blood is occasionally attributed to the presence of testicular toxicants. Reversing the deleterious effects of these toxicants can be achieved by the administration of free radical scavengers: i.e. ascorbic acid, which also reduces resuscitative fluid needs and complications.101,102 Immunologically speaking, thermal insults exert a considerable effect, in terms of global depression, on the immune system, notably cellular immune responsiveness. The immunodeficiency seen in burn patients is thought to be due to attenuated expression of bone marrow Granulocyte Colony Stimulating Factor (G-CSF) receptors rather than decreased GCSF levels.103 Although the loss of skin and the mechanical barrier it provides contributes to infection in burn patients, it has long been established that impaired immune mechanisms are key factors in post-burn bacterial, viral and fungal infections. Such vulnerabilities are attributed to qualitative and quantitative compromises in all components of the immune system.
Burn metabolism management strategies
To date, not a single therapeutic modality has been successful in completely reversing the complex reactions induced by a burn injury; nevertheless, several non-pharmacological and pharmacological strategies have been found to effectively modulate burn-associated metabolism.
So far, early excision and closure of the burn wound have been described as the greatest advancement in the management of patients with severe thermal injuries. In fact, this strategy remains the single most important management modality to decrease the rate of complications associated with severe burn injuries. Patients undergoing total excision and wound coverage with autograft and/or cadaveric skin within the initial 72 hours following severe thermal injury (50% TBSA) have metabolic rates 40% less than those with similar burn severity that are not excised and covered within a week.61 Furthermore, immediate excision and resurfacing have been found to offer additional advantages in terms of net protein loss, infection/sepsis rate and pain compared to delayed primary reconstructions. 104,105,106 Compared to autografts, biosynthetic skin substitutes and human cadaver skin have demonstrated equal effectiveness in early reconstructions.107,108,109
Since sepsis plays a major role in boosting burn-associated mortality and morbidity related to hypermetabolic response, every effort should be made to control the rate of sepsis by taking the appropriate measurements to prevent infection in burn patients.110
Adequate nutrition and proper feeding are of utmost importance in the recovery process of burn patients. Unlike oral nutrition alone, continuous enteral usually succeeds in preserving total body weight and decreases hypermetabolic response in burn patients.111,112,113,114,115,116 Enteral feeding remains the gold standard nutrition for burn patients. It preserves gastrointestinal motility and reduces microorganisms’ translocation and sepsis. Should the patient have absolute contraindications for enteral feeding such as prolonged ileus and enteral nutrition intolerance or in cases where enteral feeding alone is not reaching the target caloric delivery, parenteral feeding can be considered. It is crucial that parenteral nutrition is avoided as much as possible due its reported adverse effects, namely immunosuppression, liver function impairment as well as increased mortality.117,118,119 Concerning the diet profile that best fits burn patients, several considerations should be taken into account that aim at maintaining lean body mass. Considering the high rates of amino acid oxidation in burn patients, protein synthesis can be stimulated and lean body mass can be maintained with a high protein, high carbohydrate diet which also increases endogenous insulin production.120
Another conservative management action that helps diminish resting energy expenditure in patients with more than 40% TBSA burn is raising the room temperature. This simple step elevates the patient’s core temperature, subsequently reducing body water evaporative loss.121
Burn wound contracture is an inevitable sequela that remains with the patient throughout life if not treated properly. Its prevention, however, remains the most adequate management modality. This can be achieved with early, progressive physical therapy with specific regimens designed to improve body mass and muscle strength.122
In an attempt to modulate burn-induced hormonal disequilibrium, several pharmacological therapeutic strategies have already been established. These can be classified into anabolic agents and anti-catabolic agents. The anabolic hormones include GH, insulin, IGF-1, oxandrolone and testosterone. The most important anti-catabolic agent remains propranolol, an adrenergic antagonist.
Recombinant human growth hormone (rhGH) has proved to modulate responses initiated by the burn in various ways. It reduces the hepatic acute phase response by increasing constitutive hepatic proteins, decreasing acute phase proteins and modulating cytokine expression.123,124 It also decreases donor site healing time,125 improves muscle protein kinetics, maintains muscular growth,126,127 stimulates protein synthesis and attenuates nitrogen loss after injury.125 However, treatment with rhGH has been associated with increased mortality rate in adult patients, thus restricting its administration.121
On the other hand, it has been demonstrated that recombinant human IGF-1 and IGFBP-3 effectively improve muscle protein synthesis in catabolic patients with significantly less adverse effects compared to GH.128,129 These agents further enhance intestinal mucosal integrity in the severely burned pediatric population,130 attenuate muscle catabolism, and improve hepatic acute phase, the inflammatory response as well as the immune response. As the clinical use of GH is restricted, it appears that recombinant human insulin-like growth factor-1 (rhIGF-1) may be a better drug to effectively attenuate postburn responses.
The employment of insulin has been advocated in burn injuries. It has proved to prevent muscle catabolism, promote muscle anabolism and preserve lean body mass without increasing hepatic triglyceride production.130,131,132
In turn, oxandrolone has gained a reasonable clinical application for the prevention and treatment of burns sequelae. As a synthetic testosterone analogue, it restores serum testosterone levels with a resultant surge in anabolic gene expression in muscles as well as a decrease in protein breakdown.133,134,135 In addition to improving muscle protein synthesis, lean body mass and bone mineral content, oxandrolone has been successful in counteracting the effects of hypermetabolism and shortening acute hospitalization.136,137,138
With the destructive effects induced by elevated body concentrations of catecholamine, anti-catabolic agents have been introduced to the burn injury management protocol. Propranolol was demonstrated to abate obligatory thermogenesis, resting energy expenditure, tachycardia and cardiac work.80,139 It was also found to be influential in increasing lean body mass and decreasing urinary nitrogen loss and whole-body urea production. Moreover, reduced insulin resistance, peripheral lipolysis, hepatic acute phase response, fatty infiltration of the liver and skeletal muscle wasting were additional advantages offered by beta-adrenergic blockers.57,140,141
Conclusion
In response to thermal insult, the human body reacts in an immediate and complex manner by releasing stress hormones and inflammatory mediators that subsequently induce vasoconstriction, increase vascular permeability, reduce diuresis, alter cellular membrane function and impair cardiac contractility. Depending on the burn size, the outcomes of these responses include, but are not limited to, decreased intravascular volume, increased systemic vascular resistance, decreased cardiac output, end-organ ischemia and metabolic acidosis. This can further lead to systemic deterioration, multi-organ failure and death when early appropriate resuscitation is not provided.
Burn-associated catabolism cannot be completely reversed but may be manipulated by non-pharmacologic and pharmacologic means. Early burn wound excision and complete wound closure, prevention of sepsis, maintenance of the patient’s thermal neutrality, and graded resistance exercises during recovery are simple, safe, reliable and successful primary treatment strategies. Anabolic and anti-catabolic agents greatly reduce lean body mass loss and linear growth delay. Continuous administration of low-dose insulin, beta-blockers (propranolol), and synthetic testosterone analogue (oxandrolone) are still the safest and most cost-effective therapeutic modalities to date.
Acknowledgments
Competing interests.The authors declare that they have no competing interests.
Funding.The authors declare that they received no funding.
References
- 1.Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403–434. doi: 10.1128/CMR.19.2.403-434.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Forjuoh SN. Burns in low and medium-income countries. A review of available literature on descriptive epidemiology, risk factors, treatment and prevention. Burns. 2006;32:529–537. doi: 10.1016/j.burns.2006.04.002. [DOI] [PubMed] [Google Scholar]
- 3.Sharma BR. Infections in patients with severe burns: Causes and prevention thereof. Inf Dis Clin N Am. 2007;21:745–759. doi: 10.1016/j.idc.2007.06.003. [DOI] [PubMed] [Google Scholar]
- 4.Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg. 1996;223:14–25. doi: 10.1097/00000658-199601000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ahuja RB, Battacharya S. Burns in the developing world and burn disasters. BMJ. 2004;329:447–449. doi: 10.1136/bmj.329.7463.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yilkok ST, Isamade ES, Oba AF. Outcome of burn patients managed in a general intensive care unit. Nig J Surg. 2005;11:1–4. [Google Scholar]
- 7.Brigham PA, McLoughlin E. Burn incidence and medical care use in the United States: estimates, trends, and data sources. J Burn Care Rehabil. 1996;17:95–107. doi: 10.1097/00004630-199603000-00003. [DOI] [PubMed] [Google Scholar]
- 8.Wolf SE. Critical care in the severely burned: organ support and management of complications. Herndon DN (ed): “Total burn care”, 3rd edition. 2007 [Google Scholar]
- 9.Yoshida T, Yoshida S, Kobayashi M, Herndon DN, Suzuki F. Pivotal advance: Glycyrrhizin restores the impaired production of β-defensins in tissues surrounding the burn area and improves the survival of burn mice to Pseudomonas aeruginosa wound infection. J Leukoc Biol. 2010;87:35–41. doi: 10.1189/jlb.1208760. [DOI] [PubMed] [Google Scholar]
- 10.Mayhall CG. Epidemiology of burn wound infections: Then and now! Clin Infect Dis. 2003;37:543–550. doi: 10.1086/376993. [DOI] [PubMed] [Google Scholar]
- 11.Vo LT, Papworth GD, Delaney PM, Barkla DH, King RG. A study of vascular response to thermal injury on hairless mice by fiber-optic confocal imaging, laser doppler flowmetry and conventional histology. Burns. 1998;24:319–324. doi: 10.1016/s0305-4179(98)00028-x. [DOI] [PubMed] [Google Scholar]
- 12.Aulick LH, Wilmore DW, Mason AD, Pruitt BA Jr. Influence of the burn wound on peripheral circulation in thermally injured patients. Am J Physiol. 1977;233:520–526. doi: 10.1152/ajpheart.1977.233.4.H520. [DOI] [PubMed] [Google Scholar]
- 13.Settle JAD. Fluid therapy in burns. J Roy Soc Med. 1982;1:7–11. [PMC free article] [PubMed] [Google Scholar]
- 14.Demling RH. Fluid replacement in burned patients. Surg Clin North Am. 1987;67:15–30. doi: 10.1016/s0039-6109(16)44130-7. [DOI] [PubMed] [Google Scholar]
- 15.Demling RH, Will JA, Belzer FO. Effect of major thermal injury on the pulmonary microcirculation. Surgery, 1978;83:746–751. [PubMed] [Google Scholar]
- 16.Baxter CR. Fluid volume and electrolyte changes of the early postburn period. Clin Plast Surg. 1974;1:693–709. [PubMed] [Google Scholar]
- 17.Baxter CR, Cook WA, Shires GT. Serum myocardial depressant factor of burn shock. Surg Forum. 1966;17:1–3. [PubMed] [Google Scholar]
- 18.Hilton JG, Marullo DS. Effects of thermal trauma on cardiac force of contraction. Burns Incl Therm Inj. 1986;12:167–171. doi: 10.1016/0305-4179(86)90154-3. [DOI] [PubMed] [Google Scholar]
- 19.Clark WR. Death due to thermal trauma. Dolecek R, Brizio-Molteni L, Molteni A, Traber D (eds): “Endocrinology of thermal trauma”. 1990:6–27. [Google Scholar]
- 20.Lund T, Reed RK. Acute hemodynamic effects of thermal skin injury in the rat. Circ Shock. 1986;20:105–114. [PubMed] [Google Scholar]
- 21.Arturson G. Pathophysiological aspects of the burn syndrome. Acta Chir Scand Suppl. 1961;274:1–135. [PubMed] [Google Scholar]
- 22.Leape LL. Kinetics of burn edema formation in primates. Ann Surg. 1972;176:223–226. doi: 10.1097/00000658-197208000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Demling RH, Mazess RB, Witt RM, Wolberg WH. The study of burn wound edema using dichromatic absorptiometry. J Trauma. 1978;18:124–128. doi: 10.1097/00005373-197802000-00009. [DOI] [PubMed] [Google Scholar]
- 24.Arturson G, Jakobsson OR. Oedema measurements in a standard burn model. Burns. 1985;1:1–7. doi: 10.1016/0305-4179(85)90176-7. [DOI] [PubMed] [Google Scholar]
- 25.Leape LL. Early burn wound changes. J Pediatr Surg. 1968;3:292–299. doi: 10.1016/0022-3468(68)90014-6. [DOI] [PubMed] [Google Scholar]
- 26.Leape LL. Initial changes in burns: tissue changes in burned and unburned skin of rhesus monkeys. J Trauma. 1970;10:488–492. [PubMed] [Google Scholar]
- 27.Lund T, Wiig H, Reed RK. Acute postburn edema: Role of strongly negative interstitial fluid pressure. Am J Physiol. 1988;255:1069–1074. doi: 10.1152/ajpheart.1988.255.5.H1069. [DOI] [PubMed] [Google Scholar]
- 28.Onarheim H, Lund T, Reed R. Thermal skin injury: II. Effects on edema formation and albumin extravasation of fluid resuscitation with lactated Ringer’s, plasma, and hypertonic saline (2,400 mosmol/l) in the rat. Circ Shock. 1989;27:25–37. [PubMed] [Google Scholar]
- 29.Shires GT, Cunningham JN, Baker CR, Reeder SF. Alterations in cellular membrane dysfunction during hemorrhagic shock in primates. Ann Surg. 1972;176:288–295. doi: 10.1097/00000658-197209000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nakayama S, Kramer GC, Carlsen RC, Holcroft JW, Cala PM. Amiloride blocks membrane potential depolarization in rat skeletal muscle during hemorrhagic shock (abstract). Circ Shock. 1984;13:106–107. [Google Scholar]
- 31.Arango A, Illner H, Shires GT. Roles of ischemia in the induction of changes in cell membrane during hemorrhagic shock. J Surg Res. 1976;20:473–476. doi: 10.1016/0022-4804(76)90122-0. [DOI] [PubMed] [Google Scholar]
- 32.Holliday RL, Illner HP, Shires GT. Liver cell membrane alterations during hemorrhagic shock in the rat. J Surg Res. 1981;31:506–515. doi: 10.1016/0022-4804(81)90189-x. [DOI] [PubMed] [Google Scholar]
- 33.Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE. Lumenal narrowing and endothelial cell swelling in skeletal muscle capillaries during hemorrhagic shock. Circ Shock. 1989;29:27–39. [PubMed] [Google Scholar]
- 34.Garcia NM, Horton JW. L-arginine improves resting cardiac transmembrane potential after burn injury. Shock, 1994;1:354–358. doi: 10.1097/00024382-199405000-00006. [DOI] [PubMed] [Google Scholar]
- 35.Evans JA, Darlington DN, Gann DS. A circulating factor(s) mediates cell depolarization in hemorrhagic shock. Ann Surg. 1991;213:549–557. doi: 10.1097/00000658-199106000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Trunkey DD, Illner H, Arango A, Holiday R, Shires GT. Changes in cell membrane function following shock and cross-perfusion. Surg Forum. 1974;25:1–3. [PubMed] [Google Scholar]
- 37.Brown JM, Grosso MA, Moore EE. Hypertonic saline and dextran: Impact on cardiac function in the isolated rat heart. J Trauma. 1990;30:646–651. [PubMed] [Google Scholar]
- 38.Button B, Baker RD, Vertrees RA, Allen SE. Quantitative assessment of a circulating depolarizing factor in shock. Shock. 15;2001:239–244. doi: 10.1097/00024382-200115030-00013. [DOI] [PubMed] [Google Scholar]
- 39.Hart DW, Wolf SE, Mlcak R, Chinkes DL. Persistence of muscle catabolism after severe burn. Surgery. 2000;128:312–319. doi: 10.1067/msy.2000.108059. [DOI] [PubMed] [Google Scholar]
- 40.Herndon DN, Abston S, Stein SD. Increased thromboxane B2 levels in the plasma of burned and septic burned patients. Surg Gynecol Obstet. 1984;159:210–213. [PubMed] [Google Scholar]
- 41.Morykwas MJ, David LR, Schneider AM, Whang C. Use of subatmospheric pressure to prevent progression of partial-thickness burns in a swine model. J Burn Care Rehabil. 1999;20:15–21. doi: 10.1097/00004630-199901001-00003. [DOI] [PubMed] [Google Scholar]
- 42.Nwariaku FE, Sikes PJ, Lightfoot E, Mileski WJ, Baxter C. Effect of a bradykinin antagonist on the local inflammatory response following thermal injury. Burns. 1996;22:324–327. doi: 10.1016/0305-4179(95)00130-1. [DOI] [PubMed] [Google Scholar]
- 43.Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg. 2006;244:121–130. doi: 10.1097/01.sla.0000217678.78472.d3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Przkora R, Barrow RE, Jeschke MG, Suman OE. Body composition changes with time in pediatric burn patients. J Trauma. 2006;60:968–971. doi: 10.1097/01.ta.0000214580.27501.19. [DOI] [PubMed] [Google Scholar]
- 45.Dolecek R. Endocrine changes after burn trauma–a review. Keio J Med. 1989;38:262–276. doi: 10.2302/kjm.38.262. [DOI] [PubMed] [Google Scholar]
- 46.Jeffries MK, Vance ML. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil. 1992;13:391–395. doi: 10.1097/00004630-199207000-00001. [DOI] [PubMed] [Google Scholar]
- 47.Klein GL, Bi LX, Sherrard DJ, Beavan SR. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int. 2004;15:468–474. doi: 10.1007/s00198-003-1572-3. [DOI] [PubMed] [Google Scholar]
- 48.Goodall M, Stone C, Haynes BW. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg. 1957;145:479–487. doi: 10.1097/00000658-195704000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Coombes EJ, Batstone GF. Urine cortisol levels after burn injury. Burns Incl Therm Inj. 1982;8:333–337. doi: 10.1016/0305-4179(82)90033-x. [DOI] [PubMed] [Google Scholar]
- 50.Norbury WB, Herndon DN. Modulation of the hypermetabolic response after burn injury. Total burn care. 2007:420–433. [Google Scholar]
- 51.Sheridan RL. A great constitutional disturbance. N Engl J Med. 2001;345:1271–1272. doi: 10.1056/NEJM200110253451710. [DOI] [PubMed] [Google Scholar]
- 52.Pereira C, Murphy K, Jeschke M, Herndon DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37:1948–1961. doi: 10.1016/j.biocel.2005.05.009. [DOI] [PubMed] [Google Scholar]
- 53.Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009;94:1656–1664. doi: 10.1210/jc.2008-1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Wolfe RR. Review: acute versus chronic response to burn injury. Circ Shock. 1981;8:105–115. [PubMed] [Google Scholar]
- 55.Reiss W, Pearson E, Artz CP. The metabolic response to burns. J Clin Invest. 1956;35:62–77. doi: 10.1172/JCI103253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jeschke MG, Chinkes DL, Finnerty CC, Julp G. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248:387–401. doi: 10.1097/SLA.0b013e3181856241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223–1229. doi: 10.1056/NEJMoa010342. [DOI] [PubMed] [Google Scholar]
- 58.Jahoor F, Desai M, Herndon DN, Wolfe RR. Dynamics of the protein metabolic response to burn injury. Metabolism. 1988;37:330–337. doi: 10.1016/0026-0495(88)90132-1. [DOI] [PubMed] [Google Scholar]
- 59.Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308:553–558. doi: 10.1056/NEJM198303103081002. [DOI] [PubMed] [Google Scholar]
- 60.Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363:1895–1902. doi: 10.1016/S0140-6736(04)16360-5. [DOI] [PubMed] [Google Scholar]
- 61.Hart DW, Wolf SE, Chinkes DL, Gore DC. Determinants of skeletal muscle catabolism after severe burn. Ann Surg. 2000;232:455–465. doi: 10.1097/00000658-200010000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Bessey PQ, Jiang ZM, Johnson DJ, Smith RJ, Wilmore DW. Posttraumatic skeletal muscle proteolysis: the role of the hormonal environment. World J Surg. 1989;13:465–470. doi: 10.1007/BF01660758. [DOI] [PubMed] [Google Scholar]
- 63.Chang DW, DeSanti L, Demling RH. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock. 1998;10:155–160. doi: 10.1097/00024382-199809000-00001. [DOI] [PubMed] [Google Scholar]
- 64.Wilmore DW. Hormonal responses and their effect on metabolism. Surg Clin North Am. 1976;56:999–1018. doi: 10.1016/s0039-6109(16)41029-7. [DOI] [PubMed] [Google Scholar]
- 65.Wilmore DW, Long JM, Mason AD Jr, Skreen RW, Pruitt BA Jr. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg. 1974;180:653–669. doi: 10.1097/00000658-197410000-00031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Gore DC, Ferrando A, Barnett J, Wolf SE. Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma. 2000;49:673–678. doi: 10.1097/00005373-200010000-00015. [DOI] [PubMed] [Google Scholar]
- 67.Herndon DN, Wilmore DW, Mason AD Jr. Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J Surg Res. 1978;25:394–403. doi: 10.1016/s0022-4804(78)80003-1. [DOI] [PubMed] [Google Scholar]
- 68.Rennie MJ. Muscle protein turnover and the wasting due to injury and disease. Br Med Bull. 1985;41:257–264. doi: 10.1093/oxfordjournals.bmb.a072060. [DOI] [PubMed] [Google Scholar]
- 69.Galster AD, Bier DM, Cryer PE, Monafo WW. Plasma palmitate turnover in subjects with thermal injury. J Trauma. 1984;24:938–945. doi: 10.1097/00005373-198411000-00003. [DOI] [PubMed] [Google Scholar]
- 70.Cree MG, Aarsland A, Herndon DN, Wolfe RR. Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance. Crit Care Med. 2007;35:476–483. doi: 10.1097/01.CCM.0000278066.05354.53. [DOI] [PubMed] [Google Scholar]
- 71.Childs C, Heath DF, Little RA, Brotherston M. Glucose metabolism in children during the first day after burn injury. Arch Emerg Med. 1990;7:135–147. doi: 10.1136/emj.7.3.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med. 1987;317:403–408. doi: 10.1056/NEJM198708133170702. [DOI] [PubMed] [Google Scholar]
- 73.Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues. 2006;17:50–55. doi: 10.1097/00044067-200601000-00007. [DOI] [PubMed] [Google Scholar]
- 74.Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2004;15:45–62. doi: 10.1097/00044067-200401000-00004. [DOI] [PubMed] [Google Scholar]
- 75.Gore DC, Jahoor F, Wolfe RR, Herndon DN. Acute response of human muscle protein to catabolic hormones. Ann Surg. 1993;218:679–684. doi: 10.1097/00000658-199321850-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Carlson GL. Insulin resistance and glucose-induced thermogenesis in critical illness. Proc Nutr Soc. 2001;60:381–388. doi: 10.1079/pns200193. [DOI] [PubMed] [Google Scholar]
- 77.Cree MG, Zwetsloot JJ, Herndon DN, Qian T. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg. 2007;245:214–221. doi: 10.1097/01.sla.0000250409.51289.ca. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol. 2002;93:1638–1643. doi: 10.1152/japplphysiol.00445.2002. [DOI] [PubMed] [Google Scholar]
- 79.Baron PW, Barrow RE, Pierre EJ, Herndon DN. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil. 1997;18:223–227. doi: 10.1097/00004630-199705000-00008. [DOI] [PubMed] [Google Scholar]
- 80.Minifee PK, Barrow RE, Abston S, Desai MH, Herndon DN. Improved myocardial oxygen utilization following propranolol infusion in adolescents with post-burn hypermetabolism. J Pediatr Surg. 1989;24:806–810. doi: 10.1016/s0022-3468(89)80541-x. [DOI] [PubMed] [Google Scholar]
- 81.Michie DD, Goldsmith RS, Mason Jr AD. Effects of hydralazine and high molecular weight dextran upon the circulatory responses to severe thermal burns. Circ Res. 1963;13:46–48. doi: 10.1161/01.res.13.5.468. [DOI] [PubMed] [Google Scholar]
- 82.Chrysopoulo MT, Jeschke MG, Dziewulski P, Barrow RE, Herndon DN. Acute renal dysfunction in severely burned adults. J Trauma. 1999;46:141–144. doi: 10.1097/00005373-199901000-00024. [DOI] [PubMed] [Google Scholar]
- 83.Jeschke MG, Barrow RE, Wolf SE, Herndon DN. Mortality in burned children with acute renal failure. Arch Surg. 1998;133:752–756. doi: 10.1001/archsurg.133.7.752. [DOI] [PubMed] [Google Scholar]
- 84.LeVoyer T, Cioffi WG Jr, Pratt L, Shippee R. Alterations in intestinal permeability after thermal injury. Arch Surg. 1992;127:26–29. doi: 10.1001/archsurg.1992.01420010032005. [DOI] [PubMed] [Google Scholar]
- 85.Wolf SE, Ikeda H, Matin S, Debroy MA. Cutaneous burn increases apoptosis in the gut epithelium of mice. J Am Coll Surg. 1999;188:10–16. doi: 10.1016/s1072-7515(98)00260-9. [DOI] [PubMed] [Google Scholar]
- 86.Carter EA, Udall JN, Kirkham SE, Walker WA. Thermal injury and gastrointestinal function. I. Small intestinal nutrient absorption and DNA synthesis. J Burn Care Rehabil. 1986;7:469–474. doi: 10.1097/00004630-198611000-00004. [DOI] [PubMed] [Google Scholar]
- 87.Deitch EA, Rutan R, Waymack JP. Trauma, shock, and gut translocation. New Horiz. 1996;4:289–299. [PubMed] [Google Scholar]
- 88.Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg. 2005;241:334–342. doi: 10.1097/01.sla.0000152013.23032.d1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg. 2005;241:334–342. doi: 10.1097/01.sla.0000152013.23032.d1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Thomas SJ, Morimoto K, Herndon DN, Ferrando AA. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery. 2002;132:341–347. doi: 10.1067/msy.2002.126871. [DOI] [PubMed] [Google Scholar]
- 91.Klein GL. Burn-induced bone loss: Importance, mechanisms, and management. J Burns Wounds. 2006;5:e5. [PMC free article] [PubMed] [Google Scholar]
- 92.Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg. 2004;139:641–647. doi: 10.1001/archsurg.139.6.641. [DOI] [PubMed] [Google Scholar]
- 93.Jeschke MG, Mlcak RP, Finnerty CC, Herndon DN. Changes in liver function and size after a severe thermal injury. Shock. 2007;28:172–177. doi: 10.1097/shk.0b013e318047b9e2. [DOI] [PubMed] [Google Scholar]
- 94.Jeschke MG, Barrow RE, Mlcak RP, Herndon DN. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg. 2005;241:759–768. doi: 10.1097/01.sla.0000161028.43338.cd. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997;181::257–266. doi: 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- 96.Jewo PI, Duru FI, Osinubi AA, Fadeyibi IO. Histological changes and testicular dysfunction in severely burned rats. Mac J Med Sci. 2011;4:227–233. [Google Scholar]
- 97.Sweeney TE, Rozum JS, Desjardin CS, Gore RW. Microvascular pressure distribution in the hamster testis. Am J Physiol. 1991;260:1581–1589. doi: 10.1152/ajpheart.1991.260.5.H1581. [DOI] [PubMed] [Google Scholar]
- 98.Patkowski D, Jelen M, Crerni KJ. The natural course of cryptorchidism in rats and efficacy of orchidopexy or orchidectomy in its treatment before and after puberty. J Paed Surg. 1992;27:870–873. doi: 10.1016/0022-3468(92)90387-m. [DOI] [PubMed] [Google Scholar]
- 99.Hikim AP, Wang CA, Leung AJ, Swerdloff RWS. Involvement of apoptosis in the induction of germ cell degeneration in adult rats after gonadotrophin- releasing hormone antagonist treatment. Endocrinol. 1995;136:2770–2775. doi: 10.1210/endo.136.6.7750502. [DOI] [PubMed] [Google Scholar]
- 100.Hikim A, Lue Y, Yamamot C, Vera Y. Key apoptotic pathways for heat-induced programmed cell death in the testis. Endocrinol. 2003;141:3167–3175. doi: 10.1210/en.2003-0175. [DOI] [PubMed] [Google Scholar]
- 101.Jewo PI, Duru FI, Fadeyibi IO, Saalu LC, Noronha CC. The protective role of ascorbic acid in burn-induced testicular damage in rats. Burns. 2011;38:113–119. doi: 10.1016/j.burns.2011.02.009. [DOI] [PubMed] [Google Scholar]
- 102.Tanaka H, Matsuda T, Miyagantani Y, Yukioda T. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: A randomized prospective study. Arch Surg. 2000;135:326–331. doi: 10.1001/archsurg.135.3.326. [DOI] [PubMed] [Google Scholar]
- 103.Shoup M, Weisenberger JM, Wang JL, Pyle JM, Gamelli RL, Shankar R. Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg. 1998;228:112–122. doi: 10.1097/00000658-199807000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Hart DW, Wolf SE, Chinkes DL, Beauford RB. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism and sepsis after severe burn. J Trauma. 2003;54:755–762. doi: 10.1097/01.TA.0000060260.61478.A7. [DOI] [PubMed] [Google Scholar]
- 105.Barret JP, Dziewulski PM, Ramzy P, Wolf SE. Biobrane versus 1% sulfadiazine in second degree pediatric burns. Plast Reconstr Surg. 2000;105:62–65. doi: 10.1097/00006534-200001000-00010. [DOI] [PubMed] [Google Scholar]
- 106.Rose JK, Desai MH, Mlakar JM, Herndon DN. Allograft is superior to topical antimicrobial therapy in the treatment of partial-thickness scald burns in children. J Burn Care Rehabil. 1997;18:338–341. doi: 10.1097/00004630-199707000-00011. [DOI] [PubMed] [Google Scholar]
- 107.Purdue GF, Hunt JL, Still JM, Law EJ. A multi-centered clinical trial of biosynthetic skin replacement dermagraft TC compared with cryopreserved human cadaver skin for temporary coverage of excised burn wound. J Burn Care Rehabil. 1997;18:52–57. doi: 10.1097/00004630-199701000-00009. [DOI] [PubMed] [Google Scholar]
- 108.Purdue GF, Hunt JL, Gillespie RW, Hansbrough JF. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma. 1987;27:155–157. doi: 10.1097/00005373-198702000-00010. [DOI] [PubMed] [Google Scholar]
- 109.Heimbach D, Luterman A, Burke J, Cram A. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988;208:313–320. doi: 10.1097/00000658-198809000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Barret JP, Herndon DN. Modulation of inflammatory and catabolic responses in severely burned children by early burn wound excision in the first 24 hours. Arch Surg. 2003;138:127–132. doi: 10.1001/archsurg.138.2.127. [DOI] [PubMed] [Google Scholar]
- 111.Newsome TW, Mason AD Jr, Pruitt BA Jr. Weight loss following thermal injury. Ann Surg. 1973;178:215–217. doi: 10.1097/00000658-197308000-00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Curreri PW, Richmond D, Marvin J, Baxter CR. Dietary requirements of patients with major burns. J Am Diet Assoc. 1974;65:415–417. [PubMed] [Google Scholar]
- 113.Wilmore DW, Curreri PW, Spitzer KW, Spitzer ME, Pruitt BA Jr. Supranormal dietary intake in thermally injured hypermetabolic patients. Surg Gynecol Obstet. 1971;132:881–886. [PubMed] [Google Scholar]
- 114.Hildreth M, Herndon DN, Desai MH, Duke M. Reassessing caloric requirements in pediatric burns. J Burn Care Rehabil. 1988;9:616–618. doi: 10.1097/00004630-198811000-00009. [DOI] [PubMed] [Google Scholar]
- 115.Mochizuki H, Trocki O, Dominioini L, Brackett KA. Mechanisms of prevention of post-burn hypermetabolism and catabolism by early enteral feeding. Ann Surg. 1984;200:297–310. doi: 10.1097/00000658-198409000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Dominioini L, Trocki O, Fang CH, Mochizuki H. Enteral feeding in burn hypermetabolism: nutritional and metabolic effects at different levels of calorie and protein intake. JPEN J Parenter Enteral Nutr. 1985;9:269–279. doi: 10.1177/0148607185009003269. [DOI] [PubMed] [Google Scholar]
- 117.Herndon DN, Stein MD, Rutan T, Abston S, Linares H. Failure of TPN supplementation to improve liver function immunity and mortality in thermally injured patients. J Trauma. 1987;27:195–204. doi: 10.1097/00005373-198702000-00018. [DOI] [PubMed] [Google Scholar]
- 118.Herndon DN, Barrow RE, Stein M, Linares H. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil. 1989;10:309–313. doi: 10.1097/00004630-198907000-00004. [DOI] [PubMed] [Google Scholar]
- 119.Jeejeebhoy KN. Total parenteral nutrition: potion or poison? Am J Clin Nutr. 2001;74:160–163. doi: 10.1093/ajcn/74.2.160. [DOI] [PubMed] [Google Scholar]
- 120.Hart DW, Wolf SE, Zhang XJ, Chinkes DL. Efficacy of highcarbohydrate diet in catabolic illness. Crit Care Med. 2001;29:1318–1324. doi: 10.1097/00003246-200107000-00004. [DOI] [PubMed] [Google Scholar]
- 121.Zawacki BE, Spitzer KW, Mason AD, Johns LA. Does increased evaporative water loss cause hypermetabolism in burned patients? Ann Surg. 1970;171:236–240. doi: 10.1097/00000658-197002000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Cucuzzo N, Ferrando AA, Herndon DN. The effects of exercise programming versus traditional outpatient therapy and rehabilitation in severely burned patients. J Burn Care Rehabil. 2001;22:214–220. doi: 10.1097/00004630-200105000-00006. [DOI] [PubMed] [Google Scholar]
- 123.Klein GL, Wolf SE, Langman CB, Rosen CJ. Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children following severe burn injury. J Clin Endocrinol Metabol. 1998;83:21–24. doi: 10.1210/jcem.83.1.4518. [DOI] [PubMed] [Google Scholar]
- 124.Singh KP, Prasad R, Chari PS, Dash RJ. Effect of growth hormone therapy in burn patients on conservative treatment. Burns. 1998;24:733–738. doi: 10.1016/s0305-4179(98)00113-2. [DOI] [PubMed] [Google Scholar]
- 125.Herndon DN, Barrow RE, Kunkel KR, Broemeling LD, Rutan RL. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg. 1990;12:424–431. doi: 10.1097/00000658-199010000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Aili Low JF, Barrow RE, Mittendorfer B, Jeschke MG. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns. 2001;27:447–452. doi: 10.1016/s0305-4179(00)00164-9. [DOI] [PubMed] [Google Scholar]
- 127.Hart DW, Herndon DN, Klein G, Lee SB. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg. 2001;223:827–834. doi: 10.1097/00000658-200106000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Moller S, Jensen M, Svensson P, Skakkebaek NE. Insulin-like growth factor 1 (IGF-1) in burn patients. Burns. 1991;17:279–281. doi: 10.1016/0305-4179(91)90039-j. [DOI] [PubMed] [Google Scholar]
- 129.Herndon DN, Ramzy PI, DebRoy MA, Zheng M. Muscle protein catabolism after severe burn: the effect of IGF-1 over IGF BP3 treatment. Ann Surg. 1999;229:713–722. doi: 10.1097/00000658-199905000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Sakurai Y, Aarsland A, Herndon DN, Chinkes DL. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222:283–297. doi: 10.1097/00000658-199509000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Aarsland A, Chinkes DL, Sakurai T, Nguyen TT. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest. 1998;101:2223–2229. doi: 10.1172/JCI200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Ferrando AA, Chinkes DL, Wolf SE, Matin S. A submaximal dose of insulin promotes skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229:11–8. doi: 10.1097/00000658-199901000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med. 2001;29:1936–1942. doi: 10.1097/00003246-200110000-00015. [DOI] [PubMed] [Google Scholar]
- 134.Barrow RE, Dasu MR, Ferrando AA, Spies M. Gene expression patterns in skeletal muscle of thermally injured children treated with oxandrolone. Ann Surg. 2003;237:422–428. doi: 10.1097/01.SLA.0000055276.10357.FB. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Hart DW, Wolf SE, Ramzy PI, Chinkes DL. Anabolic effects of oxandrolone following severe burn. Ann Surg. 2001;233:556–564. doi: 10.1097/00000658-200104000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Sheffield-Moore M, Urban RJ, Wolf SE, Jiang J. Short-term oxandrolone administration stimulates muscle protein synthesis in young men. J Clin Endocrinol Metabol. 1999;84:2705–2711. doi: 10.1210/jcem.84.8.5923. [DOI] [PubMed] [Google Scholar]
- 137.Demling RH, DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma. 1997;43:47–51. doi: 10.1097/00005373-199707000-00012. [DOI] [PubMed] [Google Scholar]
- 138.Wolf SE, Thomas SJ, Dasu MR, Ferrando AA. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. Ann Surg. 2003;237:801–810. doi: 10.1097/01.SLA.0000071562.12637.3E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Herndon DN, Barrow RE, Rutan TC, Minifee P. Effect of propranolol administration on human dynamic metabolic response of the burned pediatric patients. Ann Surg. 1988;208:484–492. doi: 10.1097/00000658-198810000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Gore DC, Honeycutt D, Jahoor F, Barrow RE. Propranolol diminishes extremity blood flow in burn patients. Ann Surg. 1991;213:568–574. doi: 10.1097/00000658-199106000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Morio B, Irtund O, Hendon DN, Wolfe RR. Propranolol decreases splanchnic triacylglycerol storage in burned patients receiving a high carbohydrate diet. Ann Surg. 2002;236:218–225. doi: 10.1097/00000658-200208000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]